Loading your page…
Marketing-authorisation holder · United States
5 medicines in 1 country, as authorisation holder.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARDIZEM100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Diltiazem | United States | Not marketed | 1991 |
| CITALOPRAM HYDROBROMIDE10mg base | 20mg base | 40mg base · Tablet, orally disintegrating | Citalopram | United States | Not marketed | 2005 |
| CITALOPRAM HYDROBROMIDE40mg · Tablet | Citalopram | United States | Marketed | 2005 |
| TOVALT ODT10mg | 5mg · Tablet, orally disintegrating | Zolpidem | United States | Not marketed | 2007 |
| VASOTEC1.25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Enalapril | United States | Not marketed | 1988 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
